Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Wilfrido Mojica
Breast Carcinoma With Amplified HER2: A Gene Expression Signature Specific for Trastuzumab Resistance and Poor Prognosis
Modern Pathology
Forensic Medicine
Pathology
Related publications
Src, a Potential Target for Overcoming Trastuzumab Resistance in HER2-positive Breast Carcinoma
British Journal of Cancer
Cancer Research
Oncology
Resistance to Trastuzumab in HER2-Positive Mucinous Invasive Ductal Breast Carcinoma
Clinical Breast Cancer
Cancer Research
Oncology
Mechanisms Behind the Resistance to Trastuzumab in HER2-Amplified Breast Cancer and Strategies to Overcome It
Clinical Medicine Insights: Oncology
Oncology
Cytokeratin 5/6 Fingerprinting in HER2-positive Tumors Identifies a Poor Prognosis and Trastuzumab-Resistant Basal-Her2 Subtype of Breast Cancer
Oncotarget
Oncology
ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer
Frontiers in Oncology
Cancer Research
Oncology
Sixteen-Kinase Gene Expression Identifies Luminal Breast Cancers With Poor Prognosis
Cancer Research
Cancer Research
Oncology
Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Gene Expression Profiling of Carcinoma Breast and Its, Prognostic Signature: A Review
Academia Journal of Surgery
Flotillin2 Expression Correlates With HER2 Levels and Poor Prognosis in Gastric Cancer
PLoS ONE
Multidisciplinary